INS and diabetes mellitus: With the advancement of designer cell-based therapies, researchers are exploring ways to treat diabetes by modifying β cells (Kitada et al., 2018) because the current treatment for patients with type 1 diabetes is still limited to blood glucose monitoring throughout the day and insulin injections.